Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178568 | SCV000230677 | uncertain significance | not provided | 2014-05-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088819 | SCV000562002 | likely benign | Primary ciliary dyskinesia | 2024-01-29 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001836744 | SCV002097932 | uncertain significance | Primary ciliary dyskinesia 7 | 2021-03-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001088819 | SCV002669760 | uncertain significance | Primary ciliary dyskinesia | 2015-12-15 | criteria provided, single submitter | clinical testing | The p.K2442R variant (also known as c.7325A>G), located in coding exon 45 of the DNAH11 gene, results from an A to G substitution at nucleotide position 7325. The lysine at codon 2442 is replaced by arginine, an amino acid with highly similar properties. This variant was previously reported in the SNPDatabase as rs114286628. Based on data from the 1000 Genomes Project, the G allele has an overall frequency of approximately 0.14% (3/2098) total alleles studied. The highest observed frequency was 1.14% (2/176) Yoruba alleles. Based on data from the NHLBI Exome Sequencing Project (ESP), the G allele has an overall frequency of approximately 0.05% (6/11828) total alleles studied, having been observed in 0.16% (6/3654) African American alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by SIFT. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Prevention |
RCV003917664 | SCV004729500 | likely benign | DNAH11-related condition | 2023-03-08 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |